Browse resources

Disease: Meningococcus

Total results with these characteristics: 192

Page 6 of 8  
‹ prev.
3
4
5
6
7
8
next ›

Meningococcal Vaccines: WHO Position Paper, November 2011

This article, published in the Weekly Epidemiological Record, summarizes the World Health Organization's recommendations on meningococcal vaccines. It incorporates the most recent developments in the field of meningococcal vaccines, including …

Author: World Health Organization

Published: 2011

Microbiological and Epidemiological Investigation of the Neisseria Meningitidis Serogroup A Epidemic in Niger in 2009: Last Wave Before the Introduction of the Serogroup A Meningococcal Conjugate Vaccine?

The authors of this article, published in Epidemiology and Infection, analyzed cerebrospinal fluid samples during the 2009 meningitis season in Niger, the largest epidemic observed in Niger since those of  to 1996 …

Author: Collard JM, Maman Z, Abani A, et al.

Published: 2011

Modelling Meningococcal Meningitis in the African Meningitis Belt

The authors of this article, published in Epidemiology and Infection, used deterministic compartmental models to investigate how well simple model structures with seasonal forcing were able to qualitatively capture patterns of meningococcal …

Author: Irving TJ, Blyuss KB, Colijn C, Trotter CL

Published: 2012

Molecular Surveillance of Meningococcal Meningitis in Africa

This article, published in the journal Vaccine, reviews the data of meningococcal strains recovered from outbreaks and epidemics in the African meningitis belt, which can provides important insights on the biology and epidemiology of this pathogen. …

Author: Caugant DA, Nicolas P

Published: 2007

Monitoring Adverse Events Following Immunization With a New Conjugate Vaccine Against Group A Meningococcus in Niger, September 2010

In Niger, the introduction campaign of MenAfriVac™, a new conjugate vaccine against Neisseria meningitidis serogroup A, was conducted in the District of Filingue, during September 2010. The authors of this article, published in …

Author: Chaibou MS, Bako H, Salisou L, et al.

Published: 2012

More About Meningococcus

This web page on the Vaccine Resource Library provides links to PATH's work on meningococcus, as well as general information about the disease and the current vaccine landscape.

Author: PATH

Published: 2013

Neisseria Meningitidis: An Overview of the Carriage State

This article, published in The Journal of Medical Microbiology, reviews currently available information about the meningococcal carriage state and identifies where gaps exist in the body of knowledge. The authors conclude that studies of the …

Author: Yazdankhah SP, Caugant DA

Published: 2004

Neisseria.org

This website aims to provide an electronic resource for all individuals interested in research and clinical aspects of the Neisseria, including Neisseria meningitidis. It includes information for scientists and clinicians on diagnosis and …

Author: University of Oxford

New Meningitis Vaccine in the Pipeline

This article, featured in Science in Africa, outlines the burden of meningoccoal disease in Africa and discusses various projects to develop a new meningococcal vaccine for Africa that can provide long-term protection across all age groups and that …

Author: Bagchi S

Published: 2004

Optimising the Use of Conjugate Vaccines to Prevent Disease Caused by Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae

This article, published in Vaccine, reviews the state of the current evidence on conjugate vaccines and identifies important areas for further study, in order to inform the debate regarding the best use of these vaccines, which not only prevent …

Author: Trotter CL, McVernon J, Ramsay ME, et al.

Published: 2008

Pediatric Bacterial Meningitis Surveillance--African Region, 2002 to 2008

This article, published in Morbidity and Mortality Weekly Report, analyzes data for 2002 to 2008 from the Pediatric Bacterial Meningitis (PBM) Surveillance Network, which collects information on laboratory-confirmed bacterial meningitis cases among …

Author: US Centers for Disease Control and Prevention

Published: 2009

Phenotypic and Genotypic Characterization of Meningococcal Carriage and Disease Isolates in Burkina Faso After Mass Vaccination With a Serogroup A Conjugate Vaccine

The conjugate vaccine against serogroup A Neisseria meningitidis, MenAfriVac, was first introduced in mass vaccination campaigns of the 1- to 29-year-olds in Burkina Faso in 2010. This study, published in BMC Infectious Diseases, genetically …

Author: Kristiansen PA, Ba AK, Sanou I, et al.

Published: 2013

The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases

This book provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on vaccine-preventable diseases. In addition to chapters on more general vaccine-related topics, it …

Author: US Centers for Disease Control and Prevention

Published: 2012

Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate Vaccines

Invasive meningococcal disease (IMD) is a serious public health threat, characterized by rapid symptom onset and high fatality rate, even after treatment. Efforts to prevent IMD remain challenging, because there is neither an immunogenic vaccine for …

Author: Poland GA

Published: 2010

Prevention of Secondary Cases of Meningococcal Disease in Household Contacts by Vaccination

This article, published in The British Medical Journal, describes a study of secondary meningococcal disease infection in which researchers used either meningococcal or tetanus toxoid vaccine to immunize household contacts of patients with …

Author: Greenwood BM, Hassan-King M, Whittle HC

Published: 1978

Priorities for Research on Meningococcal Disease and the Impact of Serogroup A Vaccination in the African Meningitis Belt

To review how the research agenda for meningococcal disease in Africa has been changed by the advent of a serogroup A polysaccharide/tetanus toxoid protein conjugate vaccine and to define a new set of research priorities for study of meningococcal …

Author: Greenwood B

Published: 2013

Product Development Partnerships Hit Their Stride: Lessons from Developing a Meningitis Vaccine for Africa

This article, published in Health Affairs, provides an overview of the Meningitis Vaccine Project as an example of how product development partnerships have reinvigorated research on vaccines for neglected diseases. The …

Author: Bishai DM, Champion C, Steele ME, Thompson L

Published: 2011

The Promise of Conjugate Vaccines for Africa

This article, published in Vaccine, emphasizes the importance of capsular polysaccharide vaccines for preventing disease caused by Neisseria meningitidis and Streptococcus pneumoniae in Africa, reiterating that these vaccines have been proven safe …

Author: Kieny MP, LaForce FM

Published: 2007

Prospective Cohort Study of Disabling Sequelae and Quality of Life in Children With Bacterial Meningitis in Urban Senegal

This article, published in the Pediatric Infectious Disease Journal, describes a study to investigate disabling sequelae among a cohort of children diagnosed with bacterial meningitis in urban Dakar, Senegal. Data from the study suggest …

Author: Edmond K, Dieye Y, Griffiths UK, et al.

Published: 2010

Prospects for Vaccine Prevention of Meningococcal Infection

This article, published in Clinical Microbiology Reviews, reviews the changing epidemiology of meningococcal disease in the United States, issues related to vaccine prevention, and recommendations on the use of the polysaccharide conjugate …

Author: Harrison LH

Published: 2006

Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global …

Author: PATH

Published: 2012

Protecting the Herd: The Remarkable Effectiveness of the Bacterial Meningitis Polysaccharide-Protein Conjugate Vaccines in Altering Transmission Dynamics

The polysaccharide-protein conjugate vaccines against the pathogens responsible for bacterial meningitis have demonstrated remarkable effectiveness, far beyond the predicted individual efficacy. Approximately half of the effectiveness of these …

Author: Stephens DS

Published: 2011

Protection From Routine Vaccination at the Age of 14 Months With Meningococcal Serogroup C Conjugate Vaccine in the Netherlands

This article, published in The Pediatric Infectious Disease Journal, reviews routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and a catch-up campaign, which has reduced the incidence of meningococcal C …

Author: de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A

Published: 2006

Protein Carriers of Conjugate Vaccines: Characteristics, Development and Clinical trials

This article, published in Human Vaccines & Immunotherapeutics, discusses the conjugate vaccines for preventing infections caused by Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis. It specifically …

Author: Pichichero ME

Published: 2013

PubMed Searches: Meningococcus

These pre-formatted PubMed searches will retrieve journal citations and available abstracts that address relevant issues related to meningococcus. Documents may be ordered through Loansome Doc if you have established an agreement with a …

Author: Various

Page 6 of 8  
‹ prev.
3
4
5
6
7
8
next ›